Results 61 to 70 of about 4,527 (138)

A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract: The HORIZON Study

open access: yes, 2019
Objective: To compare cataract surgery with implantation of a Schlemm canal microstent with cataract surgery alone for the reduction of intraocular pressure (IOP) and medication use after 24 months.
Nguyen, Quang   +46 more
core   +1 more source

Development of a microstent system for minimally invasive glaucoma surgery

open access: yes, 2017
Glaucoma is the leading cause of irreversible blindness worldwide. An increased intraocular pressure (IOP) is known as major risk factor. Currently, drainage devices that are implanted by means of minimally invasive glaucoma surgery (MIGS) represent a ...
Wolfram Schmidt   +9 more
core   +2 more sources

Comparative outcomes of phacoemulsification combined with micro-invasive glaucoma surgery plus: Schlemm canal microstent versus Ab interno trabecular excision

open access: yes, 2023
To report the relative efficacy of combining phacoemulsification with a Schlemm's canal microstent (Phaco/Hydrus) or dual blade trabecular excision (Phaco/KDB). Retrospective study.
Chang, T.C.   +5 more
core   +1 more source

Which Patients Would Most Likely to Benefit: MIGS or MEGS, Which One Is It? [PDF]

open access: yes, 2019
The availability of ab interno minimally invasive glaucoma surgery (MIGS) has promoted an international interest in this procedure. Our purpose is to define the role of MIGS in the constant evolving glaucoma treatment algorithm.
Richard K. Parrish   +8 more
core   +1 more source

Radial compliance of porcine Fallopian tubes ex vivo – perspectives for the development of a gynecological microstent

open access: yes, 2023
Fallopian tube occlusions represent one of the most common causes of female sterility. As an innovative treatment approach for affected persons, we previously presented the concept of a novel polymeric, self-expanding, and bioresorbable microstent.
Dierke Ariane   +10 more
core   +1 more source

Mid-term real world outcomes of the Hydrus<sup>®</sup> Microstent in open angle glaucoma. [PDF]

open access: yesEye (Lond)
To evaluate the mid-term clinical results and the safety aspects of the Hydrus® Microstent (Ivantis, Inc, Irvine, CA) in a real-life setting.Retrospective case series.Hydrus® Microstent was implanted in phakic eyes (88 eyes, 87.1%) and in pseudophakic eyes (13 eyes, 12.9%), respectively.
Kiramira D   +5 more
europepmc   +3 more sources

Evaluation of loading behavior of a selfexpanding polymeric microstent for the treatment of Fallopian tube occlusions

open access: yes, 2023
Female sterility is caused by Fallopian tube occlusions in one of three cases. Current treatment methods achieve unsatisfying pregnancy rates and are associated with high costs or significant psychological and physiological stress.
Dierke Ariane   +10 more
core   +1 more source

Ab interno trabecular bypass surgery with Schlemm's Canal Microstent (Hydrus) for open angle glaucoma [PDF]

open access: yes, 2017
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The main objective is to assess the results at two years of ab interno trabecular bypass surgery with Hydrus for OAG in comparison to conventional medical, laser, or ...
Gazzard, G, Hu, K, Otarola, F, Bunce, C
core   +1 more source

Effect of the Hydrus microstent in patients with glaucoma [PDF]

open access: yes, 2019
Es gibt in der Behandlung des Glaukoms verschiedene operative Behandlungsansätze. Keines der aktuell bestehenden Verfahren kann das Glaukom heilen.
Meier, Leonie
core  

Outcomes of the 63-µm Gelatin Microstent Versus 45-µm Gelatin Microstent An International Multicenter Study [PDF]

open access: yes
PURPOSE: To compare 12-month effectiveness and safety of 63-μm gelatin microstent (Xen63) versus 45-μm gelatin microstent (Xen45). DESIGN: Multicenter, retrospective cohort study.
Lenzhofer, Markus   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy